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ABSTRACT 
 
Palliative care is a multidisciplinary approach that improves the quality of life in terminally ill patients and their 
families. Squamous cell carcinoma of the head and neck is one of the most common cancers seen in developing 
countries including India, constituting up to 25% of the overall cancer burden. There is an ever growing number of 
cancer patients around the globe and so is the mortality rate associated with it. These patients are not only 
compromised on general health but also on oral health, alleviation of pain, reducing the suffering, providing relief, 
treatment of any other complications which occur during the treatment or post treatment of the cancer patients are 
taken care in palliative care. The role of an oral physician is formidable in carrying out the duties and serving a 
‘Healing hand’ in Palliative oral care. 
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History 
 
Palliative care is the specialized medical care, holistic 
multidisciplinary approach for people with terminal 
illness. According to WHO, Palliative care is, “The study 
and management of patients with active, progressive, far 
advanced disease in whom the oral cavity has been 
compromised either by disease directly or by its treatment, 
the focus of care is quality of life”. [1] The term palliative 
care is not only used in regards to cancer but also with any 
other chronic terminally ill diseases like pulmonary 
disorders, renal diseases and chronic heart failure. 
Palliative care is provided by a team of health care 
professionals who provide an extra layer of support to the 
patients. [2] An oral physician plays a significant role in 
rendering these services to the patients especially with 
oral cancer patients.  
 
Oral cancer and palliative care 
 
Oral cancer has an annual incidence of 275,000 for oral 
and 130,000 for pharyngeal cancers [3]. Although the  
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oral cavity is easily accessible for direct visual 
examination, cases of oral squamous cell carcinoma 
(OSCC) are not diagnosed until an advanced stage, 
causing a very minimal survival rate. Despite modern 
treatment advances available, approximately 50% of all 
cancer patients die from the disease, thus the central focus 
has shifted from cure or life prolongation to palliation [4]. 
 
Pre treatment protocol in palliative care 
 
Oral health care professionals may come across several 
problems affecting the oral cavity either during the 
treatment or after the treatment given to cancer patients. 
Managing the oral cavity even before the cancer 
therapeutic therapy poses many challenges to oral 
physicians. Thus a comprehensive oral evaluation should 
be advised at least one month before the treatment to 
allow an adequate recovery time [5]. Orodental treatments 
must be completed before beginning either radio or 
chemotherapy so as to minimize any oral changes and 
possible adverse reactions. Periodontal prophylactic 
therapy is done to reduce the bacterial load. A ten minute 
application of 1.1% neutral pH or 0.4% stannous fluoride 
gel is advised to prevent radiation caries. All interventions 
should be completed fourteen days before radiation 
therapy so as to provide appropriate healing time for the 
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oral tissues [6]. The pre assessment treatment protocol for 
treating oral cancer patients is as following: 
 Oncologic consultation is indicated prior to any 
invasive procedures.  
 Use of an aqueous alcohol free chlorhexidine 
mouthwash (10ml of 0.2% aqueous alcohol free 
chlorhexidine gluconate mouthwash or 18ml of 0.12% 
aqueous chlorhexidine gluconate solution twice daily 
for at least one week prior to commencing treatment) 
with thorough oral hygiene practices showed evidence 
that it reduces the incidence of oral complications [7].  
 Teeth with doubtful prognosis, with direct association 
with the tumor or the radiation beam should be 
extracted before radiotherapy. 
 Extractions have to be done with minimal trauma and 
ideally three weeks for maximal healing to be given 
before the treatment [8, 9]. 
 Oral surgical procedures should be performed at least 
seven to ten days before the patient receives 
myelosuppressive chemotherapy. 
 This protocol has to be followed in order to minimize 
any potential risks during the treatment, post treatment 
and to establish an adequate standard of oral hygiene 
[7]. 
 
Oral care protocol in palliative care 
 
This protocol has to be followed at least every four hours 
for the palliating patients. 
1. Dentures if present must be removed and 
brushed thoroughly with a denture brush. 
 If patient has candidiasis, dentures should be soaked 
each night in Nystatin suspension. 
 Water soluble jelly is applied to lips as they are often 
dry. 
2. A soft bristled toothbrush has to be used for 
brushing in a sweeping motion towards the occlusal 
surfaces. 
 If bleeding occurs during brushing, then bristles must 
be soaked in hot water first and then be used. 
 An extra soft bristled toothbrush can also be used. 
3.      Rinsing of the mouth to be done, with any alcohol 
free product. 
 A mixture of hydrogen peroxide and saline (1:1) or 
chlorhexidine mouthwash. 
 Half a tablespoon of salt and baking soda and eight 
ounces of water or club soda can be used as a mouth 
rinse. 
 Saline or tap water can be used as a final rinse [10]. 
 
Control of pain in palliative care 
 
Pain is the most “An unpleasant sensory and emotional 
experience associated with actual or potential tissue 
damage, or described in terms of such damage.” as given 
by the International association for the study of pain 
(IASP) [11]. In patients receiving radiation and intense 
chemotherapy therapy, oropharyngeal pain is not an 
uncommon problem. Oral mucosal pain is also an 
important and a frequent complaint reported by head & 
neck cancer patients. Thus alleviating the pain and 
suffering for the patients is of the greatest help which can 
be rendered by an oral physician.To manage mucosal 
pain, topical Doxepin rinse, 0.5% can be advised which 
has an analgesic effect and thus reduces the pain due to 
cancer or cancer therapy. Doxepin is a dibenzexipin 
tricyclic compound. The mechanism of action is both 
central and peripheral. It is also used in the management 
of depression and chronic pain [12]. About 90% of the 
physical pain can be controlled by the application of 
WHO analgesic ladder [13] as shown in Figure 1 
 
 
 
 
Fig   1: WHO   analgesic ladder for treating cancer pain. 
  
Step 1 (Mild pain) – Non-opioids ± adjuvant 
Example is paracetamol 500 mg-1g  6 hourly. If pain is not controlled in 24 h proceed to step 2. 
Step 2 (Mild to moderate pain) - Weak opioids ± step 1 medication 
A combination of paracetamol, dextropropoxyphene, codeine or tramadol. If step 2 medications are not 
adequate in 24 h, proceed to step 3. 
Step 3 (Moderate to severe pain) - Strong opioids ± step one medication 
Morphine 5 mg four hourly, a maximum daily dose of 30 mg is required 
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 Cachexia and palliative care 
 
Cancer cachexia is a multifactorial syndrome 
characterized by progressive weight loss, and persistent 
erosion of host body cell mass in response to a 
malignant growth leading to death. Anorexia, the loss 
of desire to eat or loss of appetite, is an important 
component causing weight loss in cancer cachexia. It 
adversely effects affects the patients’ ability to fight 
against infection and withstand treatment by 
chemotherapy and radiotherapy [14] 
 
Social well being in palliative care 
 
Families of patients receiving palliative care are also 
affected immensely by the challenges of the illnesses. 
They are referred to as ‘Hidden patients’. They play an 
important role both as a care giver and care recipient. 
Palliative care has tended to focus not only on the 
needs of cancer patients but also on their families. 
Health care professionals must view the family as a 
unit of care and must support them with necessary 
assistance [15].  
 
 
 
Psychotherapy in palliative care 
 
During the palliative phase, patients should be rendered 
psychological support. Psychological interventions for 
managing persistent cancer pain have been advocated 
as adjuncts to pharmacological techniques but little 
work has been done to evaluate these interventions. 
Cognitive behavior training, relaxation, hypnosis and 
therapist support, positive affirmations are a few 
psychotherapeutic techniques. Hypnosis reduces the 
oral pain experienced by patients due to mucositis [16]. 
 
Palliative oral care & role of an oral physician 
 
Oral complications severely impact the quality of life 
and the general well being. An early definitive clinical 
diagnosis is required to minimize the pain and 
suffering for the patients and to manage oral conditions 
like xerostomia, mucositis, radiation caries, taste 
disorders and candidiasis caused due to the treatment 
and post treatment. Oral physician is the only one who 
has profound knowledge about these manifestations, 
complications and to manage them proficiently. Table 
1 shows therapeutic agents available in India for the 
treatment of oral manifestations seen during the 
treatment and post treatment phases.  
 
Table 1: shows therapeutic modes available in India for the treatment of oral manifestations seen during the 
treatment and post treatment phases 
 
 
ORAL MUCOSAL CONDITION 
 
THERAPEUTIC MODES 
 
 
 
ORAL MUCOSITIS 
 
 
1. Allopurinol mouthwash QID as a prophylactic measure. 
2. Magic mouthwash(diphenhydramine (12.5 mg per 5 ml), and lidocaine 2% viscous solution 
mixed in equal proportions (1:1) 5ml swish and spit QID. 
3. Tab Morphine- 2.5-5mg QID for 5 to 7 days. 
4. Coolora mouthwash (Benzydamine hydrochloride 0.15% -QID swish and spit. 
5. Cryotherapy(application of ice 5 minutes before the treatment  and 30 minutes after treatment 
reduces the complications. 
 
 
CANDIDIASIS 
1. Clotrimazole 0.1% (Candid mouth paint) application BID/TID for 5 days. 
2. Nystatin (Nistin-C) 5 lac unit –powdered and mixed with glycerin suspension - 1ml to swish and 
swallow QID for 7-10 days. 
3.Tab Fluconazole-50- 100mg/day for 7-10 days TID 
 
 
 
 
XEROSTOMIA 
  
1. Hydration includes, frequent water intake. 
2. Salivary substitutes (E saliva spray) TID/QID. 
3. Wet mouth – half or full Capsule swish for 30seconds. 
4. Duestom salivary substitute gel (Glycerine 18%) QID before/after the meals. 
5.Sialogogues; Tab Pilocarpine (Salagen) 5-7.5 mg – TID can be titrated to 10mg 
 
 
RADIATION CARIES 
1.Oral hygiene procedures 
2. Daily topical application of 1%NaF gel or 0.4% SnF for 5  
minutes, later stages, 15 min- TID.  
 
 
 DYSGUESIA 
 
1.Tab Zinc Sulfate (Zincovate  tab) 15-30mg/day BID for 3 months 
2. Use of Mono sodium glutamate in food. 
3. Dietary alterations, more of fruits, less salt and sugars. 
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Current scenario of palliative care in India 
 
Although Palliative care has emerged into a new 
specialty much awareness is not yet created among the 
Indian population. Government of Kerala has declared 
palliative care as a part of primary health care. It has 
developed into an integrated health service unit with 
community participation making Kerala become the 
first state in India to announce a palliative care policy. 
Many more states in India have to start adopting 
palliative care policy and the services must be made 
easily and readily available for them as these patients 
prefer being at home in the last phase of life. 
 
Conclusion 
 
Palliative care has emerged into a new specialty, with 
various healthcare professionals involved.  It is well 
understood that it’s not complete without the 
participation of oral physician.  Oral physicians are 
better equipped to interact with patients at their 
terminal stage of life as they can contribute with utmost 
care and empathy. They are certainly at a forefront in 
providing appropriate palliative oral care for cancer 
patients through operative, preventive and emotional 
care. Palliative care patients require special dental 
attention and an oral physician plays a lead role in 
improving the quality of life.  
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